We then studied the hypertrophic heart rat (HHR) as a normotensive inbred polygenetic model of adult cardiac hypertrophy and failure that begins life with a smaller heart and fewer cells 1, 2 . Neonatal male (day 2, n=11 HHR, n=10 NHR), adolescent (4-week old, n=4 HHR and n=4 NHR for cardiomyocyte isolation), young adult (13 weeks-old, n=7 HHR, n=7 NHR) and old adult (50 weeks-old, n=11 HHR, n=10 NHR) age-matched animals were euthanized by decapitation (neonatal) or with an overdose of pentobarbitone (Lethobarb) (adult animals). The heart was immediately removed, and the ventricles were dissected from the atriums. Cardiac weight index (CWI, mg/g) was calculated from the total heart weight (mg) relative to total body weight (g) of the animal. HHR samples presented hypertrophy since 4 weeks of age (data not shown). Plasma was also collected. An environmental model of left ventricular hypertrophy developed using Wistar Kyoto (WKY) rats by intra-uterine growth restriction induced by uteroplacental insufficiency on day 18 of pregnancy (term=22 days) was also investigated 3, 4 . Six month old male operated animals (n=3) were compared to WKY sham rats (n=7). For all samples, the tissues used were first preserved in liquid nitrogen and later transferred to a -80 o
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Isolation of cardiomyocytes and other cells
Cardiomyocytes were isolated from whole NHR and HHR hearts as we previously described 2 . After 10 min incubation, cardiomyocytes were deposited in the bottom of tubes. The supernatant was considered to contain other cells than cardiomyocytes. Cardiomyocytes or other cells were pelleted by centrifugation at 4,000 RCF for 5 min in a refrigerated bench top centrifuge. Total RNA was extracted from both cardiomyocytes and other cells for each sample using the miRNeasy kit (Qiagen) as described above. cDNA and qPCR were performed as described above.
Real-time Quantitative PCR (qPCR)
First-strand complementary synthesis reaction was performed using the High Capacity cDNA Reverse Transcription Kit (Life Technologies). Primers were designed to flank an exon-exon junction using Primer3 5 and NCBI tool Primer Blast. Primers and conditions used for all qPCR are shown in Online Table 1 . Amplification reactions used the SensiFast TM SYBR Low-ROX Kit qPCR reagent system (Bioline) in a Viia7 qPCR instrument (Life Technologies). Samples were run in duplicates. The specificity of the qPCR was ensured by melting curve analysis and electrophoresis in agarose gels (data not shown). The glyceraldehyde 3-phosphate dehydrogenase (Gapdh) was used as reference transcript. Significance was assessed by 2 -ΔΔCT method 6 .
Plasma measurement of LCN2
In animal samples, after euthanasia, blood was immediately collected in EDTA tubes and centrifuged. Plasma was stored separately. Lcn2 plasma and left ventricle levels were measured by enzyme-linked immunosorbent assay (ELISA) in duplicates in neonatal and adult HHR and NHR using the Lipocalin-2 Rat ELISA Kit (Abcam) according to the supplier. Human plasma collected in heparin tubes was used to measure LCN2 levels using the Quantikine ELISA Human Lipocalin-2 Immunoassay (R&D Systems) according to the supplier. Inter-and intra-assay coefficients of variability were calculated and only less than 15% variability was accepted (hence 7 human samples were excluded from further analyses). The overall intra-assay coefficient was 4.3% and the inter-coefficient was 4.5%.
Immunohistochemistry
Immunohistochemistry was performed using an anti-LCN2 Rabbit Polyclonal antibody (1:200 dilution, OriGene Technologies, TA322583), followed by the EnVision+System-HRP (Dako). In immunohistochemistry images, the positive staining (Lcn2) was the standard brown while the counterstain was haematoxylin (stains blue). Images were obtained in an EVOS® XL Cell Imaging System (Life Technologies) microscope using a 400x magnification.
Protein measurement of Lcn2 by Western Blots
Protein was extracted from left ventricle of 13 week old HHR and NHR by the use of RIPA buffer (Sigma-Aldrich) and 1% Halt Protease & Phosphatase Inhibitor Cocktail (Thermo Scientific). Fifty micrograms of extracted rat proteins were resolved by 4-15% Mini-PROTEAN® TGX™ Precast Gel (BioRad). Proteins were electroblotted on to a Nitrocellulose Membrane (Thermo Scientific). Membranes were blocked for two hours in 5% skim milk, then incubated overnight at 4 o C with Anti-LCN2 Rabbit Polyclonal antibody (1:2500 dilution, OriGene Technologies, TA322583) or β-actin (1:5000 dilution, Cell Signalling, 3700) in blocking solution, followed by several washing steps in PBS-Tween 20, 1 h at RT with secondary antibody (Lcn2: Anti-rabbit HRP-linked Antibody, 1:5000 dilution, Cell Signalling, 7074S; and β-actin: Anti-mouse HRP-linked Antibody, 1:5000 dilution, Cell Signalling, 7076S) in blocking solution, and several washing steps in PBSTween 20, before detection by enhanced chemiluminescence SuperSignal West Pico Substrate (Thermo Scientific) according to the manufacturer's instructions. Images were captured with a UVITEC Alliance digital imaging system (Thermo Scientific). Bands were quantified using Image J software, and Lcn2 protein levels were calculated as a ratio relative to β-actin. Both 25 kDa monomer Lcn2 and Lcn2 complexed with matrix metallopeptidase 9 (Mmp9) were measured.
DNA sequencing
Sanger sequencing was used to sequence 10,000 base pairs (bp) before and 2,000 bp after the Lcn2 gene (primers and conditions in Online Table 1 ). Briefly we extracted DNA using PureLink® Genomic Extraction kit (Life Technologies), and then amplified it with IMMOLASE DNA Polymerase (Bioline) in a themocycler (BioRad). PCR fragments were purified using the Wizard® SV Gel and PCR Clean-Up System (Promega) and send out for sequencing at AGRF. We sequenced the DNA of both HHR and NHR and align them to the sequence of both SHR and Fisher 344 (the two strains which originated the HHR and NHR), and the reference genome from the Rat Genome Database (version 5).
Lcn2-knockout
Whole body and heart size of adult (12-13 week-old) whole-body Lcn2 knockout (Lcn2-KO, n=6) and age-matched wild-type mice C57BL/6 (n=4) were measured upon death, and CWI was calculated as described above. Both Lcn2-KO and wild-type mice were sourced from Prof Alan Aderem (University of Washington) 7 .
Vector containing Lcn2
The pExpress vector containing the cDNA for the rat Lcn2 (Thermo Scientific, catalogue number ID MRN1768-98079404) was transformed into JM109 competent cells (Promega). Constructs were cultivated in plates of Luria-Bertani (LB) medium containing agar and ampicillin (50 μg/ml). Individual colonies were selected and the presence of the vector was confirmed by restriction enzyme and Sanger sequencing. The colonies containing the vector were cultured in LB medium overnight, and plasmids were extracted using a PureLink™ HiPure Plasmid Filter Kit (Life Technologies). To create an empty pExpress vector to be used as a control, Lcn2 sequence was cut out of the plasmid using the restriction enzymes Not1 and SmaI (Promega). DNA Polymerase I Large (Klenow) Fragment (Promega) was used to generate blunted ends. The product was run in a 1% agarose gel, and the band of the correct size was purified from the gel using the Wizard SV Gel and PCR Clean-Up system (Promega). 163 ng of this purification was ligated using T4 DNA Ligase (Life Technologies), and this was transformed into competent cells as described above. The sequence of both plasmids has been confirmed by Sanger DNA sequencing using T7 and sp6 universal primers as a service at the Australian Genome Research Facility (AGRF) as a service.
H9c2 Cell Transfections
The rat embryonic ventricular myocardial cells (H9c2: ATCC® CRL1446™) were grown in Dulbecco's modified Eagle's medium (DMEM), containing 10% fetal bovine serum (FBS) (all from Life Technologies) at 37 o C with 5% CO2. Cell culture medium was replaced every 48-72 hours. This cell line was specifically chosen because it has similar hypertrophic properties as rat primary neonatal cardiomyocytes. 8 The cells were purchased from ATCC, and short tandem repeats (STR) profiling was not available for this rat cell line. Moreover, cells were regularly tested for mycoplasma contamination using Hoechst staining (Life Technologies) and a Nikon C2 confocal microscope, with negative results during experiments. H9c2 cells were cultured in 6-to 24-well plates and transfected with 2ng/ml of Lcn2 or empty (pExpress only) plasmid using Lipofectamine 2000 TM (Life Technologies) in cells at 50% confluence. Untransfected and mock controls were also included. Preliminary experiments were used to determine the best concentration of cells, reagents and vector to have similar levels of Lcn2 as in HHR, so copying physiological levels (Fig. S6) . The minimum concentration of vector and transfection reagents, according to the manufacturer's recommendations, were used. All in vitro experiments were independently repeated 3 times, each time in triplicates (i.e., total of 9 biological replicates). Experiments always included Lcn2 vector, empty plasmid, untransfected cells and a positive control.
RNA-sequencing and molecular pathways
Total RNA was extracted from whole snap-frozen hearts of Lcn2-KO mice and cells transfected with Lcn2 plasmid for 48h (and respective controls) using the miRNeasy Mini kit (Qiagen). The RNA from 3 samples of each group was sent to RNA-sequencing at AGRF according to the manufacturer's instructions using the Illumina HiSeq platform (v3 chemistry 100bp paired-end sequencing). Each sample was considered an individual sample and no pooling was performed.
Read quality was assessed using the FastQC software version 0.10.1 (www.bioinformatics.babraham.ac.uk/projects/fastqc/), revealing high quality sequence and base scores (mean PHRED scores: overall=35.8, 1bp start=32.4, 100bp end=31.5), and thus read trimming was not applied. Analysis of differential expression was performed in the R statistical programming environment (version 3.1.0) using Rsubread (version 1.14.2) and edgeR (version 3.6.8) Bioconductor packages 9 . Paired-end 100bp Illumina reads were aligned to mouse (UCSC mm10 assembly) and rat genomes (UCSC rn5 assembly) at the gene-level using Rsubread aligner with 82.4% and 92.1% of reads successfully mapped overall for mouse and rat samples, respectively. For individual sample and alignment characteristics (i.e. number of paired reads, % mapped, indels, etc) see Online Table 2 .
Differential expression (DE) of genes was assessed with edgeR. Genes with 1-countper-million mapped reads or less in at least one of the samples were filtered out due to unreliable data in any sample. Count data was then normalized by finding a set of scaling factors for the library sizes that adjust for compositional differences between samples and also help account for any biases due to changes in highly expressed genes 10 . Scaling factors were calculated using the trimmed mean of M values (TMM) method 9, 11 . Biological coefficient of variation (BCV) was estimated using the common dispersion method (negative binomial dispersion by conditional maximum likelihood) for both mouse (BCV=0.250) and rat (BCV=0.023) samples. Both values were above the threshold (BCV=0.01) suggested for technical replicates in the edgeR User's Guide indicating sufficient biological variability for analysis. BCV is derived from total CV, which is the sum of estimated true biological (BCV) and technical variation (i.e. measurement error) across libraries. Gene-specific dispersions were then estimated using the empirical Bayes method (tagwise negative binomial) where expression differences that are consistent between replicates are more highly weighted than those that are not, which is necessary so that DE is not driven by outliers. DE was calculated by computing genewise exact tests for differences in the means between both groups (wildtype and knockout in mouse, control and transfected in rat) of negative-binomially distributed counts in edgeR. P-values were adjusted for multiple testing using the Benjamini-Hochberg correction 12 with a FDR<0.05.
To check experimental data quality with sample clustering and heatmaps, variance stabilized expression values (i.e. normalized for variation library size/sequencing depth) were generated using the R package DESeq (version 1.16.0) 13 . This data was entered for the top 100 (ranked by unadjusted P-value, all P<0.01) differentially expressed genes into principal component analysis (PCA), hierarchical cluster analysis (HCA), gene-gene heatmap and gene-sample heatmap analysis in R. PCA and HCA confirmed control and experimental group differences (data not shown) and also provided further insight into genes that are associated with the main experimental manipulations in both the rat and mouse studies.
GO enrichment analysis was performed on filtered lists (all genes with unadjusted edgeR P-value<0.05, including 529 and 721 rat and mouse genes, respectively) of differentially expressed genes using Database for Annotation, Visualization and Integrated Discovery (DAVID) 14, 15 to ask which Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways were enriched in genes differentially expressed in both mouse and rat samples. Circular plots were produced with the R package Rcircos (version 1.1.2) 16 and show the top 100 differentially expressed genes ranked by edgeR P-value and enriched pathways identified in KEGG.
Number of cells and cell size
We counted the number of cells after 48 hours of transfection by haemocytometry with the use of a Countess ® Automated Cell Counter (Life Technologies). Wheat germ agglutinin (WGA) and Hoechst staining were performed as previously described to measure cell size 17 . Cell size was measured in 10 different fields per slide obtained in a Nikon C2 confocal microscope using a 400x magnification. 823 cells in average were measured for each condition. Angiotensin II (Sigma-Aldrich) added to the cells for 48h at final concentration of 0.1 µM was used as a positive control.
Cell cycle arrest
To estimate cell proliferation, we counted phospho-histone H3 (pH3) stained cells after transfection with Lcn2 vector as described above. 500 nM of colcemid (Merck Biosciences), added 2 hours before fixing cells, was used as positive control. Briefly, cells on 12mm poly-D-lysine/laminin coated coverslips were stained with pH3 and DAPI for fluorescence imaging as described somewhere else 18 . We used the primary pH3 anti-rabbit antibody (Millipore, Cat# 06-570, 1:100 dilution) and secondary goat anti-rabbit AlexaFluor-488 antibody (Invitrogen, 1:500 dilution). Ten images per slide were obtained in a Nikon C2 confocal microscope using a 200x magnification (Fig. S7 ).
Apoptosis
Cell death and apoptosis were measured by flow cytometry using an Annexin-V: FITC Apoptosis Detection Kit I (BD Pharmingen, Cat No. 556547). Cells were detached from plate by mild trypsinization (Life Technologies) and were washed twice with cold phosphate buffer saline (PBS). Cells were then resuspended in binding buffer and stained with annexin-V-FITC and propidium iodide as per manufacturer's protocol. The stained cells were analysed using FACS Aria II (BD Biosciences). The data analysis was performed using FCS express (version 4) research edition analytical software. 100 nM staurosporine was used as a positive control.
Human Samples
Two independent cohorts were used (Online Tables 3 and 4) . One hundred and twenty one subjects were selected from a prospective cohort of type-2 diabetes (Online Table 3) 19 . Left ventricle (LV) structure and function was studied using transthoracic echocardiographyAcuson Sequoia 512 (Acuson, Mountain View, CA, USA) with 3.5 MHz scanning frequency phased-array transducer. From the ultrasound images, LV structure, systolic and diastolic function were measured following the guidelines of American Society of Echocardiography, as previously described 20, 21 . Cardiac hypertrophy was defined as LV mass indexed to the body surface of > 95 g/m 2 in women and > 115 g/m 2 in men 19 . E/E'-ratio was calculated using the average values of lateral and septal e' velocity 21 . Other phenotypes, including blood pressure, were also available. Subjects with chronic kidney disease were excluded due to previous association with LCN2 in the literature 22 . Plasma samples were collected in heparin tubes, and stored at -80 ºC. All subjects gave informed consent and the study was approved by human ethics committee at the Austin Hospital, and ratified at Federation University Australia.
The Cardiovascular Risk in Young Finns Study (YFS) is an ongoing population-based prospective study started in 1980 to study the emergence and progression of cardiovascular disease risk factors from childhood 23 . 4,320 individuals from six age groups (3, 6, 9, 12, 15, and 18 years of age) were randomly recruited from the five major population centres of Finland (Helsinki, Kuopio, Turku, Oulu, and Tampere). A total of 3,596 individuals participated in the original study and 2,064 individuals responded to the 2011 follow-up study. Transcriptome-wide microarray profiling, genome-wide genotyping, GlycA, and echocardiography measurements were available for subsets of these 2,064 individuals [24] [25] [26] [27] . Baseline cohort characteristics are provided in Online Table 3 . Ethics were approved by the Joint Commission on Ethics of the Turku University and the Turku University Central Hospital.
Venous blood samples were collected after an overnight fast and serum samples were aliquoted and stored at -70ºC. Samples were collected after an overnight fast for the YFS cohort 23 .
GlycA measurement
A proton nuclear magnetic resonance platform (Bruker AVANCE III, 500 MHz spectrometer) was used to quantify the concentrations of 106 circulating lipids, proteins, and metabolites from serum (including GlycA and total triglycerides) in the YFS cohort. Detailed experimental protocols are described in 28 .
CRP measurement
High-sensitivity C-reactive protein (CRP) was quantified from YFS serum samples using an automated analyser with a latex turbidimetric immunoassay kit.
Coexpression networks and quantitative trait locus
Transcriptome wide microarray profiling was performed on whole blood for 1,650 individuals in the YFS as previously described 24 . Briefly, stabilised total RNA was obtained from whole blood for individuals in the YFS using the PAXgene Blood RNA System. An Eppendorf BioPhotometer was used to evaluate RNA concentrations and purity and the isolation process validated using an Agilent RNA 6000 Nano Chip Kit. RNA was hybridized to Illumina HT-12 (version 4) BeadChip arrays and raw probe data was exported with the Illumina BeadStudio software. Negative control probes were used to background correct the microarrays. Both positive and negative control probes were used to quantile normalised using the limma R package 29 . Probe intensities were reported on a log2 scale.
Coexpression was calculated for genes composing the previously described neutrophil module 30 as the Spearman correlation coefficient between the gene expression microarray data. The average probe intensity across samples was taken for genes with multiple probes (DEFA1B, OLFM4, COL17A1). Edges in the interaction network were defined as the absolute value of the coexpression exponentiated to the power 4 as in 30 . The connectivity of each gene was calculated as the sum of edge weights to all other genes in the module then scaled by the connectivity of DEFA1B; the most connected gene. The scaled connectivity is a measure of biological importance to the network 31 . A summary profile of module expression was calculated as the first eigenvector of a principal components analysis of the module's gene expression data 32 . The summary expression profile explained 57% of the variance the module's gene expression matrix.
Genome-wide genotyping was carried out on whole blood samples for 2,442 individuals participating in the 2001 follow-up study of the YFS as previously described 25 . Sample and genotype quality control was performed for these 2,442 individuals. Briefly, DNA was extracted and genotyped on a custom 670K Illumina BeadChip array sharing 562,643 SNPs with the Illumina 610 BeadChip array. The custom array removed poorly performing SNPs from the 610 array and improved copy number variation coverage 25 . Genotypes were called using the Illuminus genotype calling algorithm 33 . 2 individuals were removed after initial clustering (call rate < 90%) and 54 samples were subsequently removed following Sanger genotyping pipeline quality control (low call rate: < 90%, failing heterozygosity tests, duplicate samples: >98% concordance on pairwise comparison, previously unknown relationship: >70% concordance on pairwise comparison, or failing Sequenom genotype fingerprinting: < 90% concordance for > 10 genotypes). 546,770 SNPs passed quality control. 3 individuals were removed due to low genotyping success (< 95%) and 1 individual was removed for failing sex checks. 51 individuals were excluded due to previous unknown close relation to another sample (pairwise identity by descent pi-hat > 0.2) and 2 individuals were removed due to cryptic relatedness. Missing genotypes and un-typed SNPs were imputed using the 1000 Genomes Phase 1 (v3) reference panel. Imputed and genotyped SNPs were subsequently excluded where the genotype calling probability for any allele < 90%, information score < 0.4, minor allele frequency < 1% or Hardy Weinberg equilibrium P-value < 5 x 10 -6 . A combined total of 6,721,082 directly genotyped and imputed SNPs passed quality control.
Module quantitative trait loci (QTLs) were identified for 1,386 individuals with matched genotype and gene expression data in the YFS through a genome-wide scan for SNPs associated with the summary expression profile using the 1.90 beta (version 3.32) software. Individual associations were tested using a linear model of minor allele dosage on neutrophil module summary expression. A SNP was considered a module QTL where P < 5 x 10 -8 (genome-wide significance). Models were adjusted for age, sex, and the first two principal components of the genotype data. The module QTL rs13297295 on chromosome 9 was further tested for an association with expression levels LCN2 using the same model. Rs13297295 was also tested for association with GlycA and CRP in the 1,712 individuals with matched genotype and GlycA or CRP levels.
LCN2 mRNA levels in human heart
We used data in the repository GEO series GSE1145 to investigate the levels of LCN2 in human idiopathic dilated hearts (n=11 control hearts and n=15 idiopathic dilated hearts). We performed a whole-genome analysis using the GEO tools, including false discovery rate (FDR) adjustment for multiple comparisons, to determine whether LCN2 was over-expressed in human idiopathic dilated hearts. 0.41 ± 0.24 E/E' ratio (log-scale)
1.55 ± 0.21 Systolic myocardial velocity (s') (cm/s) measured from lateral wall 13.7 ± 3.3 measured from medial wall 11.0 ± 1.9 Isovolumic relaxation time (IVRT) (ms) measured from lateral wall 104 ± 22 measured from medial wall 123 ± 25 Mitral E-wave declaration time (DT) (ms) 217 ± 38 Legend: Data presented as mean ± standard deviation and proportions n (%). LV: left ventricle; BMI: body mass index; CRP: C-reactive protein; CVD: cardiovascular disease. Prevalent disease indicates events occurring prior to sample collection while incident disease indicates events occurring after sample collection. 
